Prosecution Insights
Prosecution Insights
Tech Center 3900 • Art Units: 1626 3991
This examiner grants 75% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18862131 | DOSAGE REGIMENS FOR TREATMENT WITH DEUTERATED JAK INHIBITORS | Non-Final OA | SUN PHARMACEUTICAL INDUSTRIES, INC. |
| 18758804 | SELECTIVE PEPTIDOMIMETIC MODULATORS OF CAV2.2 (N-TYPE) VOLTAGE-GATED CALCIUM CHANNELS AND USES THEREOF | Non-Final OA | University of Pittsburgh - Of the Commonwealth System of Higher Education |
| 18868772 | CRYSTALLINE FORMS OF SODIUM (5-(4-BROMOPHENYL)-6-(2-((5-BROMOPYRIMIDIN-2-YL)OXY)ETHOXY)PYRIMIDIN-4-YL)(SULFAMOYL)AMIDE | Non-Final OA | IDORSIA PHARMACEUTICALS LTD |
| 18867628 | CRYSTAL FORMS OF TRIAZINE DIONE DERIVATIVE AND PREPARATION METHOD THEREFOR | Non-Final OA | Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
| 18951579 | CHIRAL N-HETEROCYCLIC CARBENE LIGAND-PROTECTED COPPER CLUSTER | Non-Final OA | Zhengzhou University |
| 18926544 | Substituted 7-(Pyrimidin-4-yl)Quinolin-4(1H)-One Compounds as Cyclin Dependent Kinase Inhibitors | Non-Final OA | BeiGene, Ltd. |
| 18858015 | MODULATORS OF INTRACELLULAR CHLORIDE CONCENTRATION FOR USE IN THE TREATMENT OF COGNITIVE DECLINE | Non-Final OA | FONDAZIONE TELETHON ETS |
| 18837121 | BICYCLIC HETEROARYL COMPOUNDS AND USES THEREOF | Non-Final OA | ETERN BIOPHARMA (SHANGHAI) CO., LTD. |
| 18711529 | AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF, IN PARTICULAR FOR A SYSTEMIC TREATMENT OF DISEASES AND CONDITIONS | Non-Final OA | Assistance Publique-Hopitaux De Paris (APHP) |
| 18003595 | Compound of Formula (I), a Semiconductor Material Comprising at Least One Compound of Formula (I), a Semiconductor Layer Comprising at Least One Compound of Formula (I) and an Electronic Device Comprising at Least One Compound of Formula (I) | Final Rejection | Novaled GmbH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy